Assessment of a circulating protease biomarker across chronic kidney disease and transplantation, integrating renal function, histopathology, and prognostic outcomes.
Key Takeaways
- Patients with CKD are at high risk of progressing to end-stage kidney disease (ESKD)
- Which have limited sensitivity and specificity for detecting early graft injury
- There is a critical need for innovative non-invasive biomarkers to enable early